Evidence map›Paper›PMID 38775067›Full record

ReviewTechnology in cancer research & treatment

The Application of Artificial Intelligence to Cancer Research: A Comprehensive Guide.

Amin Zadeh Shirazi, Morteza Tofighi, Alireza Gharavi, Guillermo A Gomez

Abstract readReview
In one paragraph

Review in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amin Zadeh ShiraziCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, Australia.
Morteza TofighiDepartment of Electrical Engineering, Faculty of Engineering, Bu-Ali Sina University, Hamedan, Iran.
Alireza GharaviDepartment of Computer Science, Azad University, Mashhad Branch, Mashhad, Iran.
Guillermo A GomezCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, Australia.ORCID 0000-0002-0494-2404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advancements in AI have notably changed cancer research, improving patient care by enhancing detection, survival prediction, and treatment efficacy. This review covers the role of Machine Learning, Soft Computing, and Deep Learning in oncology, explaining key concepts and algorithms (like SVM, Naïve Bayes, and CNN) in a clear, accessible manner. It aims to make AI advancements understandable to a broad audience, focusing on their application in diagnosing, classifying, and predicting various cancer types, thereby underlining AI's potential to better patient outcomes. Moreover, we present a tabular summary of the most significant advances from the literature, offering a time-saving resource for readers to grasp each study's main contributions. The remarkable benefits of AI-powered algorithms in cancer care underscore their potential for advancing cancer research and clinical practice. This review is a valuable resource for researchers and clinicians interested in the transformative implications of AI in cancer care.

Indexed as

AlgorithmsArtificial IntelligenceNeoplasmsBiomedical ResearchHumansMachine Learningartificial intelligencecancerdeep learningmachine learningmachine visionsoft computing

Identifiers

PMID38775067
PMCPMC11113055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.